STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough prostate cancer
Disease control CompletedThis study tested whether adding a precise, high-dose radiation treatment (SBRT) to the drug apalutamide helps men with a type of advanced prostate cancer that no longer responds to standard hormone therapy. The cancer had spread to only a few spots in the body. The main goal was…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
New drug combo shows promise in slowing prostate cancer spread
Disease control CompletedThis study looked at whether adding a drug called axitinib to standard hormone therapy before surgery could help control prostate cancer that had spread to lymph nodes. Seventy-three men with previously untreated prostate cancer participated. The goal was to see if the combinatio…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC